Meet Jeuveau® (prabotulinumtoxinA-xvfs) injection–a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults for a period of time (temporary).
So, what’s the difference between Jeuveau and Botox?
Like Botox, Dysport, and Xeomin, Jeuveau is used to temporarily improve the appearance of frown lines and wrinkles. Like Botox, Jeuveau has a molecular weight of 900 kDa, but they’re produced in different facilities and are derived from different strains of the same toxin. (Botox, or onabotulinumtoxinA, is made by Allergan in Westport, Ireland; Jeuveau, or prabotulinumtoxinA, comes out of Seoul, South Korea.) The risks and potential side effects listed by the companies are also identical.
The main draw for consumers is that Jeuveau’s parent company, Evolus, has announced plans to price the product competitively. Whereas Botox has medical indications (treating migraines, etc.), and was in fact first used in the medical market before it was approved for cosmetics, Jeuveau is purely cosmetic and not subject to any insurance coverage or reimbursement. Skirting medical-industry vetting saves the company and providers money, and patients by extension.